Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B-Reference-Cited by-同舟云学术

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

Published:2010-01-04 Issue:2 Volume:51 Page:422-430
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Chang Ting-Tsung,Lai Ching-Lung,Kew Yoon Seung,Lee Samuel S.,Coelho Henrique Sergio M.,Carrilho Flair Jose,Poordad Fred,Halota Waldemar,Horsmans Yves,Tsai Naoky,Zhang Hui,Tenney Daniel J.,Tamez Ricardo,Iloeje Uchenna

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23327/fullpdf

Reference26 articles.

1. Viral hepatitis B;Lai;Lancet,2003

2. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepatol,2004

3. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

4. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

5. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update;Keeffe;Clin Gastroenterol Hepatol,2008

Cited by 519 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating metabolites are associated with persistent elevations of ALT in patients with chronic hepatitis B with complete viral suppression;Journal of Medical Virology;2024-06

2. CRISPR-Cas13b-mediated suppression of HBV replication and protein expression;Journal of Hepatology;2024-05

3. Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA;Emerging Microbes & Infections;2024-04-16

4. Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future;Journal of Clinical Medicine;2024-04-02

5. Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agents;World Journal of Hepatology;2024-03-27